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INTRODUCTION
PROBLEM STATEMENT
USING PAT TO SET MONITORING
AND CONTROL STRATEGIES 
CHEMOMETRIC MODELS FOR
CONTINUOUS BIOPROCESSING  
CHEMOMETRIC MODELS FOR
CONTINUOUS BIOPROCESSING  (Continued)  
BENEFITS
OUTLOOK
Advanced technologies and computational modeling is an overall 
capability upgrade to be used in conjunction with our existing and planned
continuous bioprocessing toolbox to enable on-line and at-line real time
continuous process analytical technology (PAT) and automation of the
continuous products. 
Pall Corporation is developing new PAT tools including both instrumentation
and computational techniques. This overall capability upgrade will be 
used in conjunction with both batch and continuous processes to enable
real time on-line and at-line monitoring, as well as advanced automation
approaches.
PAT adds value to batch processes and paves the way for continuous 
manufacturing through timely measurements of critical process parameters
(CPPs) and critical quality attributes (CQAs) across both raw and in-process
materials, allowing better process understanding and optimized control.
u Identify CQAs that affect the product quality in the continuous 
process 
– Cell density, protein concentration, aggregation, host cell protein (HCP), 
glycosylation, etc.
u Identify CPPs that affect CQAs during the continuous process
u Implementation of PAT-based measurements and controls 
(in addition to sensors)
– Analytical instrumentation capable of characterizing CQAs of interest
– Develop chemometric models by using chemometric tools
– Software for PAT method development, data management, and system 
integration
Value of PAT / multivariate data analysis (MVDA) implementation:
u Ensure consistent product quality and increase robust overall 
manufacturing performance, reducing heterogeneity
u Enable end-to-end continuous process by implementing lean and flexible 
biomanufacturing
u Advanced computational tools support continuous monoclonal antibody
production
u Process time and cost savings can be achieved through automation and
continuous integration in existing facilities
The media was spiked with common metabolites or chemicals (CaCl2 [shown], 
glutamax, glucose, NaOAc, and IgG) found in the bioreactor, and Raman spectra
was collected to build preliminary partial least square (PLS) models. 
This proof-of-concept shows that Raman has the potential for qualitative analysis
during an upstream bioreactor run.
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Qualitative Process Monitoring via Principal Components 
Analysis (PCA)
u Runs 1 and 2 were known deviations, with different resin and buffer, high
conductivity noted in the final CQAs. This PCA model confirms that as 
runs 1 and 2 have low scores on the principal component (PC) 1, which has a
strong influence by conductivity in the loadings plot.
u When a model was built with batches without any deviations, these batches are
flagged as outliers, one can drill down in the residuals to determine that the
conductivities were high. Having this knowledge in real-time can allow operators
to make adjustments immediately and move the process back into the ‘golden
batch zone’.
Gaining a better process understanding during biotherapeutics process
development will reduce the cycle time for deviation investigations,
problem analysis and implementation of corrective actions: 
u During process development, we seek to understand the CQAs needed to
achieve the desired product
u Process that uses quality-by-design (QbD) principles is followed:
– Understanding how CPPs affect the CQAs
– Gain understanding of the relationship between CQAs and CPPs
– Develop a multivariate model that defines how variability of the CPPs affects
the CQAs in order to produce a quality product
u Increase product quality and robust overall manufacturing performance
u Enable end-to-end continuous process by implementing lean and flexible 
biomanufacturing
u By reducing off-line analytical testing, ultimately time to perform the analysis 
of critical attributes in real-time is increased and quality is improved
Once relationship between CPPs and CQAs is achieved, PAT-based 
measurements, monitoring and control can be used to ensure quality and 
increase overall manufacturing performance.
The ideal continuous controls platform combines analytics and process
control strategy, empowering users to execute advanced processes
with excellence in quality, yield, and return on investment
Identifying and Comparing New Technologies 
A new technology using refractive index was compared with the current 
ultraviolet-visible spectroscopy (UV/Vis) approach for measuring the protein
content during capture. The loadings shown here prove that the index of refractivity
(IoR) is highly correlated with the UV results, and is not affected by conductivity or
pH due to the fact that each PC is by definition orthogonal to the others.
Figure 4
A PCA model was built on data from 2 days of experiments of the protein capture unit 
operation. The loadings plot shows that the IoR corresponds well to the UV2 response, and 
is not affected by changes in the conductivity or pH.
Figure 2
Raman spectra of media spiked with
CaCl2 ranging from 0.625 g/L to 10 g/L,
also pure CaCl2. There are differences
seen in the bands from ~1300 cm-1 to
~1550 cm-1, which corresponds well 
with the pure component spectra.
Figure 3
A PLS model was created based on a 
gravimetric method for reference. 
We see a good linearity across the full range,
with the exception on the 2.5 g/L sample. 
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PCA of 10 runs during protein capture. The explained variance plot (lower right) shows that 
2 components cover 90% of the total variation in the measured variables. The correlation 
loading plot shows that the PC1 explains the variations in pump pressures, pH, and 
conductivity, and the PC2 is mostly the UV responses. High conductivity was noted for runs
1 and 2, which is confirmed in the scores plot.
